Inactive Instrument

Press Releases Dermira, Inc.

Equities

US24983L1044

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Dermira : Form 15-12B - Securities Registration Termination	20-03-02	PU
Dermira : SEC Filing - S-8 POS	20-02-20	PU
Dermira : SEC Filing - POS AM	20-02-20	PU
Dermira : Lilly Completes Acquisition of Dermira	20-02-20	PR
Dermira : Statement of Ownership	20-02-10	PU
Eli Lilly and : Lilly Announces Agreement to Acquire Dermira	20-01-13	AQ
WeissLaw LLP Investigates Dermira, Inc.	20-01-10	PR
DERMIRA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	20-01-10	AQ
Dermira : Lilly Announces Agreement to Acquire Dermira	20-01-10	PR
Dermira : Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	19-12-11	AQ
Dermira : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19-12-10	BU
Dermira : Receives Fast Track Designation from FDA for Lebrikizumab for the Treatment of Atopic Dermatitis	19-12-10	BU
Dermira : to Participate in December Investor Conferences	19-11-27	BU
Dermira : Presents New Scientific Research Findings from the Lebrikizumab Program at Leading International Itch Conference	19-11-14	BU
Dermira : Elects Halley E. Gilbert to its Board of Directors	19-11-13	BU
Dermira : to Participate in the Guggenheim Healthcare Talks Idea Forum, Neuro/Immunology Day	19-11-11	BU
Dermira : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19-11-08	BU
Dermira : Reports Third Quarter 2019 Financial Results and Provides Corporate Update	19-11-05	BU
Dermira : to Report Third Quarter 2019 Results and Host Conference Call on Tuesday, November 5, 2019	19-10-29	BU
Dermira : Presents Data From Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis at Fall Clinical Dermatology Conference	19-10-17	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Dermira, Inc.

Equities

US24983L1044

Press Releases

Filters